Disruptive Tech Research
  • About
  • Media
  • Research
  • Subscribe
  • Log in
Select Page

ICYMI – Week of June 22, 2020

by Lou Basenese | Jul 1, 2020 | ICYMI

Analysts and insiders getting more bullish about Provention Bio (PRVB) and another strong rally for Atomera (ATOM) as Russell 2000 rebalance approaches

ICYMI – Week of June 15, 2020

by Lou Basenese | Jun 22, 2020 | ICYMI

The week started off with a flurry of data and developments from Cue Biopharma (CUE) and Provention Bio (PRVB), along with a rally for Atomera (ATOM)

ICYMI – Week of June 1, 2020

by Lou Basenese | Jun 8, 2020 | ICYMI

Russell 2000 Index annual rebalance list to be announced this week and likely includes three of our active recommendations.

ICYMI – Week of September 23, 2019

ICYMI – Week of September 23, 2019

by Lou Basenese | Sep 30, 2019 | ICYMI

Provention Bio (PRVB) closes a deal with high-quality life sciences investors. Then, insiders get back to buying. All while the market pivots to “risk-off”

ICYMI – Week of September 16, 2019

ICYMI – Week of September 16, 2019

by Lou Basenese | Sep 23, 2019 | ICYMI

Provention Bio (PRVB) prints a deal with top life sciences investors and it’s Cue Biopharma’s (CUE) turn to rally above key resistance levels

ICYMI – Week of September 9, 2019

ICYMI – Week of September 9, 2019

by Lou Basenese | Sep 16, 2019 | ICYMI

Small caps got back to rallying and management teams hit the conference circuit, including Provention Bio (PRVB) and Resonant Inc (RESN).

« Older Entries

Your account

Sign in

Research Links

  • Real-Time Blog
  • Active Recs
  • Archive

Recent Posts

  • Q2 2022 Portfolio Review & Outlook
  • ATOM: Lands Another “Major” Foundry Customer, Plus 10 Takeaways From Q1 Report
  • [IMNM] Biotech Absurdity
  • [Video] Cue Biopharma Q&A Session With Dr. D.J. Verret
  • [Video] ATOM: 5 Key Takeaways From The Q4 2021 Report
  • RESN: Time To Lock In Our 5G Gains
  • [CUE] “That Data Is Amazing!” So Why Is The Stock Down?